Naari completes acquisition of ANDAs from Intas Pharmaceuticals
The portfolio acquired comprises eight US FDA approved ANDAs and two products pending approval Naari Pharma has entered…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.